Project

Other

June 30, 2014

First Year project meeting held in Paris, France.

Location: MAS Paris

Hosting partner: ICO Institut de Cancérologie de l'ouest Paul Papin

March 21, 2014

Project Review Meeting held in Brussels, Belgium.

Location: REA - Research Executive Agency of the European Commission

December 4, 2013

Mid Term project meeting held in Vienna, Austria.

Location: Austria Trend Hotel Schloss Wilhelminenberg

Hosting partner: AMEDA Labordiagnostik GmbH

 

Summer 2013

CARESS project has been posted into the MyEuropa 2013 Awards (ongoing project session). The Project will be kept  posted and will participate in the next edition:

http://www.europeanprojects.org/awards2013

 

May 17, 2013

Project kick-off meeting held in Pomezia (RM), Italy

Hosting partner: IRBM Science Park s.r.l.

 

May 1, 2013

CARESS project started - funded by the European Union Seventh Framework Programme (FP7/2007-2013), managed by the REA - Research Executive Agency under the Grant Agreement n° 315398

 

A New Co: IRBM PROMIDIS, a discovery stage company

Housed in dedicated biology and chemistry laboratories within the IRBM Science Park and fully integrated within the facility, IRBM PROMIDIS (PROtein MIsfolding DISeases) is a discovery stage company focused on finding disease modifying therapies for protein aggregation disorders. With a special interest in genetic diseases, IRBM Promidis focuses efforts on addressing the mutant form of the protein, developing translationally relevant assays which can be applied for screening and/or diagnostic purposes.

IRBM PROMIDIS is active in three complementary and synergistic areas of the drug discovery process, namely the exploitation of known mutant protein clearance mechanisms for therapeutics development, the definition of novel mechanisms to control mutant protein levels/activity/conformation and the development of translational assays for sensitive and quantitative protein detection for use as pharmacodynamic and disease progression biomarkers.

The management team, from Multinational Companies as Siena Biotech and Novartis, has many years of operational experience and success in innovative drug discovery, propelling several drug candidates from conception to advanced Phase 2 and 3 clinical testing. The management team has an excellent track record of publications and is well known in the fields of Huntington’s and neurodegenerative disease research.

 

MEDICA 2013

November 20 - 23, 2013  -  Düsseldorf, Germany

MEDICA held every year in November in Düsseldorf is the world's largest exibition dedicated to health care. Within more than 40 years it became an important event not to missed by professionals active in the health care business. About 4.500 exhibitors from 70 countries present their products and services in 17 exhibition halls.

AMEDA Labordiagnostik GmbH will exhibit at this event - hall 3, booth no. D 52

 

The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013), managed by the REA - Research Executive Agency under the Grant Agreement n° 315398